Research menu
Jump to menu

Publications:  Dr Angus Cameron

Hetmanski JHR, de Belly H, Busnelli I, Waring T, Nair RV, Sokleva V, Dobre O, Cameron A et al.(2019). Membrane Tension Orchestrates Rear Retraction in Matrix-Directed Cell Migration. Developmental Cell vol. 51, (4) 460-475.e10.
Hetmanski JHR, de Belly H, Nair RV, Sokleva V, Dobre O, Cameron A, Gauthier N, Lamaze C et al. (2019). Membrane tension orchestrates rear retraction in matrix directed cell migration. INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY. vol. 100, A44-A45.
Zur Nedden S, Orset C, Haellewyn B, Freret T, Fresser F, Eith R, Cameron AJM, Parker PJ et al. (2018). ADORA2A-mediated protection of ischemia-reperfusion injury. Role of protein kinase N1: A new player in the pathophysiology of experimental stroke. PURINERGIC SIGNALLING. Conference: PURINERGIC SIGNALLING vol. 14, S50-S50.
Tsui C, Martinez-Martin N, Gaya M, Maldonado P, Llorian M, Legrave NM, Rossi M, MacRae JI et al.(2018). Protein Kinase C-β Dictates B Cell Fate by Regulating Mitochondrial Remodeling, Metabolic Reprogramming, and Heme Biosynthesis. Immunity vol. 48, (6) 1144-1159.e5.
Claus J, Patel G, Autore F, Colomba A, Weitsman G, Soliman TN, Roberts S, Zanetti-Domingues LC et al.(2018). Inhibitor-induced HER2-HER3 heterodimerisation promotes proliferation through a novel dimer interface. eLife vol. 7,
Nedden SZ, Eith R, Schwarzer C, Zanetti L, Seitter H, Fresser F, Koschak A, Cameron AJM et al.(2018). Protein kinase N1 critically regulates cerebellar development and long-term function. Journal of Clinical Investigation vol. 128, (5) 2076-2088.
Murray ER, Cameron AJM(2017). Towards specific inhibition of mTORC2. Aging vol. 9, (12) 2461-2462.
Hurst CD, Alder O, Platt FM, Droop A, Stead LF, Burns JE, Burghel GJ, Jain S et al.(2017). Genomic Subtypes of Non-invasive Bladder Cancer with Distinct Metabolic Profile and Female Gender Bias in KDM6A Mutation Frequency. Cancer Cell vol. 32, (5) 701-715.e7.
Cameron AJM, Veeriah S, Marshall JJT, Murray ER, Larijani B, Parker PJ(2017). Uncoupling TORC2 from AGC kinases inhibits tumour growth. Oncotarget vol. 8, (49) 84685-84696.
Cenciarelli C, Marei HE, Felsani A, Casalbore P, Sica G, Puglisi MA, Cameron AJM, Olivi A et al.(2016). PDGFRα depletion attenuates glioblastoma stem cells features by modulation of STAT3, RB1 and multiple oncogenic signals. Oncotarget
Quétier I, Marshall JJT, Spencer-Dene B, Lachmann S, Casamassima A, Franco C, Escuin S, Worrall JT et al.(2016). Knockout of the PKN Family of Rho Effector Kinases Reveals a Non-redundant Role for PKN2 in Developmental Mesoderm Expansion. Cell Reports vol. 14, (3) 440-448.
Martin-Liberal J, Cameron AJ, Claus J, Judson IR, Parker PJ, Linch M(2014). Targeting protein kinase C in sarcoma. Biochimica et Biophysica Acta - Reviews on Cancer vol. 1846, (2) 547-559.
Linch M, Riou P, Claus J, Cameron AJ, de Naurois J, Larijani B, Ng T, McDonald NQ et al.(2014). Functional implications of assigned, assumed and assembled PKC structures. Biochem Soc Trans vol. 42, (1) 35-41.
Linch M, Sanz-Garcia M, Rosse C, Riou P, Peel N, Madsen CD, Sahai E, Downward J et al.(2013). Regulation of polarized morphogenesis by protein kinase C iota in oncogenic epithelial spheroids. Carcinogenesis vol. 35, (2) 396-406.
Linch M, Sanz-Garcia M, Soriano E, Zhang Y, Riou P, Rosse C, Cameron A, Knowles P et al.(2013). A cancer-associated mutation in atypical protein kinase Cι occurs in a substrate-specific recruitment motif. Science Signaling vol. 6, (293)
Claus J, Cameron AJM, Parker PJ(2013). Pseudokinase drug intervention: a potentially poisoned chalice. Biochem Soc Trans vol. 41, (4) 1083-1088.
Cameron AJM, Linch MD, Saurin AT, Escribano C, Parker PJ(2011). mTORC2 targets AGC kinases through Sin1-dependent recruitment. Biochem J vol. 439, (2) 287-297.
Cameron AJM(2011). Occupational hazards: allosteric regulation of protein kinases through the nucleotide-binding pocket. Biochem Soc Trans vol. 39, (2) 472-476.
Rosse C, Linch M, Kermorgant S, Cameron AJM, Boeckeler K, Parker PJ(2010). PKC and the control of localized signal dynamics. Nat Rev Mol Cell Biol vol. 11, (2) 103-112.
Cameron AJM, Parker PJ(2010). Protein kinase C - a family of protein kinases, allosteric effectors or both?. Adv Enzyme Regul vol. 50, (1) 169-177.
Cameron AJM, Escribano C, Saurin AT, Kostelecky B, Parker PJ(2009). PKC maturation is promoted by nucleotide pocket occupation independently of intrinsic kinase activity. Nat Struct Mol Biol vol. 16, (6) 624-630.
Cameron AJ, Procyk KJ, Leitges M, Parker PJ(2008). PKC alpha protein but not kinase activity is critical for glioma cell proliferation and survival. Int J Cancer vol. 123, (4) 769-779.
Saurin AT, Durgan J, Cameron AJ, Faisal A, Marber MS, Parker PJ(2008). The regulated assembly of a PKCepsilon complex controls the completion of cytokinesis. Nat Cell Biol vol. 10, (8) 891-901.
Durgan J, Cameron AJ, Saurin AT, Hanrahan S, Totty N, Messing RO, Parker PJ(2008). The identification and characterization of novel PKCepsilon phosphorylation sites provide evidence for functional cross-talk within the PKC superfamily. Biochem J vol. 411, (2) 319-331.
Cameron AJ, De Rycker M, Calleja V, Alcor D, Kjaer S, Kostelecky B, Saurin A, Faisal A et al.(2007). Protein kinases, from B to C. Biochem Soc Trans vol. 35, (Pt 5) 1013-1017.
Hillyard DZ, Nutt CD, Thomson J, McDonald KJ, Wan RK, Cameron AJM, Mark PB, Jardine AG(2007). Statins inhibit NK cell cytotoxicity by membrane raft depletion rather than inhibition of isoprenylation. Atherosclerosis vol. 191, (2) 319-325.
Cameron AJ, De Rycker M, Calleja V, Alcor D, Kjaer S, Kostelecky B, Saurin A, Faisal A et al.(2007). Protein kinases, from B to C. Biochemical Society Transactions vol. 35, (5) 1013-1017.
Hillyard DZ, Cameron AJM, McDonald KJ, Thomson J, MacIntyre A, Shiels PG, Panarelli M, Jardine AG(2004). Simvastatin inhibits lymphocyte function in normal subjects and patients with cardiovascular disease. Atherosclerosis vol. 175, (2) 305-313.
Hillyard DZ, Jardine AG, McDonald KJ, Cameron AJM(2004). Fluvastatin inhibits raft dependent Fcgamma receptor signalling in human monocytes. Atherosclerosis vol. 172, (2) 219-228.
Cameron AJM, McDonald KJ, Harnett MM, Allen JM(2002). Differentiation of the human monocyte cell line, U937, with dibutyryl cyclicAMP induces the expression of the inhibitory Fc receptor, FcgammaRIIb. Immunol Lett vol. 83, (3) 171-179.
McDonald KJ, Cameron AJM, Allen JM, McLay JS, Jardine AG(2002). A pathophysiological role for tubular Fc receptors in glomerulonephritis?. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY vol. 13, 175A-175A.
Hillyard DZ, Cameron AJM, McIntyre AH, Hadden MH, Marshall HE, Johnston N, Jardine AG(2002). Inhibition of proliferation and signalling mechanisms in human lymphocytes by fluvastatin. Clin Exp Pharmacol Physiol vol. 29, (8) 673-678.
McDonald KJ, Cameron AJM, Allen JM, Jardine AG(2002). Expression of Fc alpha/mu receptor by human mesangial cells: a candidate receptor for immune complex deposition in IgA nephropathy. Biochem Biophys Res Commun vol. 290, (1) 438-442.
Cameron AJ, Harnett MM, Allen JM(2001). Differential recruitment of accessory molecules by FcgammaRI during monocyte differentiation. Eur J Immunol vol. 31, (9) 2718-2725.
Cameron AJ, Allen JM(1999). The human high-affinity immunoglobulin G receptor activates SH2-containing inositol phosphatase (SHIP). Immunology vol. 97, (4) 641-647.
Melendez A, Floto RA, Cameron AJ, Gillooly DJ, Harnett MM, Allen JM(1998). A molecular switch changes the signalling pathway used by the Fc gamma RI antibody receptor to mobilise calcium. Curr Biol vol. 8, (4) 210-221.
Cameron AJ, Allen JM(1997). Differential expression of the human high affinity IgG receptor Fc gamma RI and associated signalling molecules in differentiated U937 monocyte cells. Biochem Soc Trans vol. 25, (3)
Leng J, Cameron AJ, Buckel S, Kennelly PJ(1995). Isolation and cloning of a protein-serine/threonine phosphatase from an archaeon. J Bacteriol vol. 177, (22) 6510-6517.
Return to top